Patient motivation, satisfaction, and coping in genetic counseling and testing for BRCA1 and BRCA2

Journal of Genetic Counseling

Volumn 9, Issue 3, 2000, Pages 219-235

  Clark, Shelly ^a   Bluman, Leslie G ^b   Borstelmann, Nancy ^b   Regan, Katherine ^a   Winer, Eric P ^b   Rimer, Barbara K ^c   Skinner, Celette Sugg ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

BRCA 1; Breast cancer; Coping; Genetic counseling; Motivation; Satisfaction

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; DECISION MAKING; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PATIENT ATTITUDE; PATIENT SATISFACTION;

EID: 0033922967     PISSN: 10597700     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009463905057     Document Type: Article

References (22)

1. American Cancer Society (1999) http://www.cancer.org/bottomsearch.html.
2. Baron R, Borgen P (1997) Genetic susceptibility for BRCA: Testing and primary prevention options. ONF 24:461-468.
3. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E: (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. JNCI 89:227-238.
4. Bluman LG, Rimer BK, Berry DA, Borstelmann N, Iglehart JD, Regan K, Schildkraut J, Winer EP (1999) Attitudes, knowledge and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. JCO 17:1040-1046.
5. Burke W, Daly M, Garber J, Botkin J, Kahn M, Lynch P, McTiernan A, Offit K, Perlman J, Peterson G, Thompson E, Varricchio C (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer: BRCA1 and BRCA2. JAMA 277:997-1003.
6. Collins F (1996) BRCA1: Lots of mutations, lots of dilemmas. NEJM 334:186-188.
7. Easton DF, Bishop DT, Ford D, Crockford GP, and the Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer. AJHG 52:678-701.
8. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, and the Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695.
9. Gallion H, Park R (1995) Developing intervention/prevention strategies for individuals at high risk of developing hereditary ovarian cancer. JNCI Monographs 17:103-106.
10. Garber J, Patenaude A (1995) Ethical, social and counselling issues in hereditary cancer susceptibility. Cancer Surveys 25:381-397.
11. Geller G, Botkin J, Green M, Press N, Biesecker B, Wilfond B, Grana G, Daly M, Schneider K, Kahn M (1997) Genetic testing for susceptibility to adult-onset cancer: The process and content of informed consent. JAMA 277:1467-1474.
12. King MC, Rowell S, Love SM (1993) Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 269:1975-1980.
13. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, TrockB, Main D, Lynch J, Fulmore C, Snyder C, Lemon S, Conway T, Tonin P, Lenoir G, Lynch H (1996) BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 275:1885-1892.
14. McConkie-Resell A, Callanan N, Adams N, Amacker-North E, Peters-Brown T, Schneider K, Stopfer J, Tutera A, Ulm J, Venne V (1996) Genetic counseling for BRCA1: A workshop report. Abstract presentation, National Society of Genetic Counselors 15th Annual Education Conference.
15. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett ML, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
16. National Action Plan on Breast Cancer and the American Society of Clinical Oncology (1997) http://www.napbc.org/napbc/hsedcurr.htm.
17. National Society of Genetic Counselors (1997) Predisposition genetic testing for late-onset disorders in adults: A position paper of the National Society of Genetic Counselors. JAMA 278:1217-1220.
18. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. NEJM 336:1401-1408.
19. Struewing J, Lerman C, Kase R, Giambarresi T, Tucker M (1995) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology, Biomarkers and Prevention 4:169-173.
20. Weber B (1996) Breast cancer susceptibility genes: current challenges and future promises. Annals Inter Med 124:1088-1090.
21. Weber B, Giusti R, Liu E (1995) Developing strategies for intervention and prevention in hereditary breast cancer. JNCI Monographs 17:99-102.
22. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Manglon J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Fleenec D, Keisell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Deville P, Cornelisse C, Lynch H, Narod S, Lenoir G, Eglisson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR (1995) Identification of the cancer susceptibility gene BRCA2. Nature 378:789-792.